Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

Media ReleaseMarking Immutep’s transition to a Phase III biotech, the Company’s pivotal TACTI-004 trial in first-line non-small cell lung cancer ...

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

Art has a way of helping people express themselves, promoting creativity and enriching critical thinking. 7News recently surprised this month’s Golden ...

SHEBOYGAN – New events and exhibits are on the horizon at Above & Beyond Children’s Museum ... owner of Elivate Co., ABCM moved from a cloud logo to loopy, rainbow text.

A US-based company has unveiled an opulent $300 million doomsday bunker complex to protect the ultrarich clients from ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being recorded. If you have any objections, you may disconnect at this time. I would ...

Ensconced in their cozy Montecito mansion, the Sussexes are living the American dream. By all accounts, the love is real. But ...

These next generation drug candidates fit synergistically with Telix's therapeutics pipeline, enabling expansion to future therapy areas with unmet clinical ... precision medicine and therapeutic ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from ...

If you have been diagnosed with schizophrenia, major depressive disorder, bipolar disorder, and general anxiety disorder, you’re allowed to withdraw up to $500 yearly for therapy and counselling.